Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	13.51B -36.5%
Revenue (ttm)	1.29B +21.1%
Net Income	213.91M +44.6%
EPS	3.21 +44.6%
Shares Out	65.86M
PE Ratio	63.96
Forward PE	32.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	112,283
Open	205.20
Previous Close	205.20
Day's Range	202.00 - 216.80
52-Week Range	165.00 - 346.40
Beta	0.49
Analysts	Strong Buy
Price Target	357.25 (+67.57%)
Earnings Date	Jul 16, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Analyst Summary

According to 5 analysts, the average rating for BONEX stock is "Strong Buy." The 12-month stock price target is kr 357.25, which is an increase of 67.57% from the latest price.

Price Target

kr 357.25

(67.57% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 28, 2026

Data Sources Report a data error